CASTLE BIOSCIENCES INC Annual Net Income (Loss) Attributable to Parent in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Castle Biosciences Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2018 to 2023.
  • Castle Biosciences Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $2.27M.
  • Castle Biosciences Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $6.08M.
  • Castle Biosciences Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$57.5M, a 14.4% increase from 2022.
  • Castle Biosciences Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$67.1M, a 115% decline from 2021.
  • Castle Biosciences Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$31.3M, a 204% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$57.5M +$9.67M +14.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$67.1M -$35.8M -115% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$31.3M -$21M -204% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 -$10.3M -$15.6M -295% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
2019 $5.28M +$11.6M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 -$6.37M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.